DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Petrylak DP, Tangen CM, Hussain MH. et al.
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
N Engl J Med 2004;
351 (15) 1513-1520
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.